Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Two Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Potential for paradigm shift in CAR-T therapy with CellPoint’s decentralized point-of-care manufacturing model, in partnership with Lonza, and AboundBio’s...
Investegate announcements from Galapagos NV, Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies
-Data featured in two oral presentations at the 8th Society of Endometriosis and Uterine Disorders Congress and a poster presentation at the International Society of Gynecological Endocrinology 20th
Investegate announcements from ObsEva SA, ObsEva Presents Clinical Data on Oral GnRH Antagonist Linzagolix at Multiple Congresses